vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.

Sprout Social, Inc. is the larger business by last-quarter revenue ($120.9M vs $83.1M, roughly 1.5× PROCEPT BioRobotics Corp). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 12.9%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 11.8%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.

PRCT vs SPT — Head-to-Head

Bigger by revenue
SPT
SPT
1.5× larger
SPT
$120.9M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+7.3% gap
PRCT
20.2%
12.9%
SPT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
11.8%
SPT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
SPT
SPT
Revenue
$83.1M
$120.9M
Net Profit
$-31.6M
Gross Margin
64.9%
77.6%
Operating Margin
-4.1%
-9.0%
Net Margin
-38.1%
Revenue YoY
20.2%
12.9%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.56
$-0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SPT
SPT
Q1 26
$83.1M
Q4 25
$76.4M
$120.9M
Q3 25
$83.3M
$115.6M
Q2 25
$79.2M
$111.8M
Q1 25
$69.2M
$109.3M
Q4 24
$68.2M
$107.1M
Q3 24
$58.4M
$102.6M
Q2 24
$53.4M
$99.4M
Net Profit
PRCT
PRCT
SPT
SPT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-21.4M
$-9.4M
Q2 25
$-19.6M
$-12.0M
Q1 25
$-24.7M
$-11.2M
Q4 24
$-18.9M
Q3 24
$-21.0M
$-17.1M
Q2 24
$-25.6M
$-16.9M
Gross Margin
PRCT
PRCT
SPT
SPT
Q1 26
64.9%
Q4 25
60.6%
77.6%
Q3 25
64.8%
77.7%
Q2 25
65.4%
77.7%
Q1 25
63.9%
77.3%
Q4 24
64.0%
78.1%
Q3 24
63.2%
77.4%
Q2 24
59.0%
77.5%
Operating Margin
PRCT
PRCT
SPT
SPT
Q1 26
-4.1%
Q4 25
-40.6%
-9.0%
Q3 25
-27.8%
-7.9%
Q2 25
-28.0%
-11.0%
Q1 25
-39.7%
-10.2%
Q4 24
-28.9%
-12.8%
Q3 24
-38.4%
-16.4%
Q2 24
-50.3%
-16.6%
Net Margin
PRCT
PRCT
SPT
SPT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-25.7%
-8.1%
Q2 25
-24.7%
-10.7%
Q1 25
-35.8%
-10.3%
Q4 24
-27.6%
Q3 24
-35.9%
-16.6%
Q2 24
-48.0%
-17.0%
EPS (diluted)
PRCT
PRCT
SPT
SPT
Q1 26
$-0.56
Q4 25
$-0.54
$-0.18
Q3 25
$-0.38
$-0.16
Q2 25
$-0.35
$-0.21
Q1 25
$-0.45
$-0.19
Q4 24
$-0.34
$-0.25
Q3 24
$-0.40
$-0.30
Q2 24
$-0.50
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SPT
SPT
Cash + ST InvestmentsLiquidity on hand
$245.6M
$95.3M
Total DebtLower is stronger
$51.7M
$40.0M
Stockholders' EquityBook value
$347.7M
$203.4M
Total Assets
$487.1M
$523.1M
Debt / EquityLower = less leverage
0.15×
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SPT
SPT
Q1 26
$245.6M
Q4 25
$286.5M
$95.3M
Q3 25
$294.3M
$90.6M
Q2 25
$302.7M
$101.5M
Q1 25
$316.2M
$100.9M
Q4 24
$333.7M
$86.4M
Q3 24
$196.8M
$82.9M
Q2 24
$214.1M
$80.9M
Total Debt
PRCT
PRCT
SPT
SPT
Q1 26
$51.7M
Q4 25
$51.6M
$40.0M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
$25.0M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
SPT
SPT
Q1 26
$347.7M
Q4 25
$365.9M
$203.4M
Q3 25
$380.3M
$194.1M
Q2 25
$385.8M
$184.6M
Q1 25
$389.2M
$175.3M
Q4 24
$402.2M
$166.6M
Q3 24
$241.2M
$158.1M
Q2 24
$251.8M
$152.1M
Total Assets
PRCT
PRCT
SPT
SPT
Q1 26
$487.1M
Q4 25
$508.1M
$523.1M
Q3 25
$511.5M
$481.4M
Q2 25
$513.1M
$422.9M
Q1 25
$519.4M
$424.7M
Q4 24
$534.0M
$428.3M
Q3 24
$374.1M
$388.8M
Q2 24
$374.4M
$393.6M
Debt / Equity
PRCT
PRCT
SPT
SPT
Q1 26
0.15×
Q4 25
0.14×
0.20×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
0.15×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
SPT
SPT
Operating Cash FlowLast quarter
$10.9M
Free Cash FlowOCF − Capex
$9.9M
FCF MarginFCF / Revenue
8.2%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$39.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
SPT
SPT
Q1 26
Q4 25
$-10.3M
$10.9M
Q3 25
$-6.6M
$9.3M
Q2 25
$-15.0M
$5.1M
Q1 25
$-17.0M
$18.1M
Q4 24
$-32.4M
$4.1M
Q3 24
$-18.8M
$9.0M
Q2 24
$-15.7M
$2.1M
Free Cash Flow
PRCT
PRCT
SPT
SPT
Q1 26
Q4 25
$-12.2M
$9.9M
Q3 25
$-9.5M
$8.5M
Q2 25
$-17.8M
$4.2M
Q1 25
$-18.8M
$16.7M
Q4 24
$-33.6M
$3.3M
Q3 24
$-19.0M
$8.5M
Q2 24
$-16.8M
$1.6M
FCF Margin
PRCT
PRCT
SPT
SPT
Q1 26
Q4 25
-15.9%
8.2%
Q3 25
-11.4%
7.4%
Q2 25
-22.5%
3.7%
Q1 25
-27.2%
15.3%
Q4 24
-49.2%
3.0%
Q3 24
-32.6%
8.3%
Q2 24
-31.4%
1.6%
Capex Intensity
PRCT
PRCT
SPT
SPT
Q1 26
Q4 25
2.4%
0.9%
Q3 25
3.4%
0.7%
Q2 25
3.5%
0.8%
Q1 25
2.7%
1.2%
Q4 24
1.7%
0.8%
Q3 24
0.4%
0.5%
Q2 24
2.0%
0.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

SPT
SPT

Segment breakdown not available.

Related Comparisons